Reply concerning "Colchicine in coronary artery disease: Role of anti-inflammatory medications redefined": Prime time for anti-inflammatory agents for the management of cardiovascular diseases

Mariama Akodad¹, Jérémy Fauconnier², Alain Lacampagne², François Roubille³

Affiliations

¹ PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, 34295 Montpellier cedex 5, France; Cardiology Department, University Hospital of Montpellier, University of Montpellier, 34295 Montpellier cedex 5, France.
² Cardiology Department, University Hospital of Montpellier, University of Montpellier, 34295 Montpellier cedex 5, France.
³ PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, 34295 Montpellier cedex 5, France; Cardiology Department, University Hospital of Montpellier, University of Montpellier, 34295 Montpellier cedex 5, France. Electronic address: f-roubille@chu-montpellier.fr.

PMID: 29407131
DOI: 10.1016/j.ijcard.2017.12.059

Free article

Comment

Reply concerning "Colchicine in coronary artery disease: Role of anti-inflammatory medications redefined": Prime time for anti-inflammatory agents for the management of cardiovascular diseases

Mariama Akodad et al. Int J Cardiol. 2018.

Free article

. 2018 Mar 1:254:52.

doi: 10.1016/j.ijcard.2017.12.059. Epub 2018 Jan 28.

Authors

Mariama Akodad¹, Jérémy Fauconnier², Alain Lacampagne², François Roubille³

Affiliations

¹ PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, 34295 Montpellier cedex 5, France; Cardiology Department, University Hospital of Montpellier, University of Montpellier, 34295 Montpellier cedex 5, France.
² Cardiology Department, University Hospital of Montpellier, University of Montpellier, 34295 Montpellier cedex 5, France.
³ PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, 34295 Montpellier cedex 5, France; Cardiology Department, University Hospital of Montpellier, University of Montpellier, 34295 Montpellier cedex 5, France. Electronic address: f-roubille@chu-montpellier.fr.

PMID: 29407131
DOI: 10.1016/j.ijcard.2017.12.059

No abstract available

Keywords: Canakinumab; Cardiovascular diseases; Colchicine; Inflammation.

PubMed Disclaimer

Comment on

Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model.
Akodad M, Fauconnier J, Sicard P, Huet F, Blandel F, Bourret A, de Santa Barbara P, Aguilhon S, LeGall M, Hugon G, Lacampagne A, Roubille F. Akodad M, et al. Int J Cardiol. 2017 Aug 1;240:347-353. doi: 10.1016/j.ijcard.2017.03.126. Epub 2017 Apr 1. Int J Cardiol. 2017. PMID: 28395979
Colchicine in coronary artery disease: Role of anti-inflammatory medications redefined.
Ashish K, Bandyopadhyay D, Mondal S, Ghosh RK. Ashish K, et al. Int J Cardiol. 2018 Mar 1;254:51. doi: 10.1016/j.ijcard.2017.11.103. Epub 2018 Jan 28. Int J Cardiol. 2018. PMID: 29407130 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply concerning "Colchicine in coronary artery disease: Role of anti-inflammatory medications redefined": Prime time for anti-inflammatory agents for the management of cardiovascular diseases

Affiliations

Reply concerning "Colchicine in coronary artery disease: Role of anti-inflammatory medications redefined": Prime time for anti-inflammatory agents for the management of cardiovascular diseases

Authors

Affiliations

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical